Literature DB >> 10576698

Peroxides as oxidative enzyme inhibitors: mechanism-based inhibition of a cysteine protease by an amino acid ozonide.

P H Dussault1, A D George, T K Trullinger.   

Abstract

A stable ozonide derived from Cbz-L-Phe accomplishes rapid and stoichiometric inhibition of papain at less than 100 microM concentration under conditions where formation of the corresponding aldehyde is negligible. Oxidation of the active site thiolate by the bound peroxide is believed to lead to formation of an inactive sulfenate or sulfenic acid. Reduction of the ozonide in excess DMSO provides a convenient method for in situ generation of a peptide aldehyde.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10576698     DOI: 10.1016/s0960-894x(99)00563-6

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Anterior Acute Uveitis Report in a SARS-CoV-2 Patient Managed with Adjunctive Topical Antiseptic Prophylaxis Preventing 2019-nCoV Spread Through the Ocular Surface Route.

Authors:  Cosimo Mazzotta; Ermete Giancipoli
Journal:  Int Med Case Rep J       Date:  2020-10-13

2.  Old Treatment for a New Disease: Can Rectal Ozone Insufflation Be Used for COVID-19 Management? A Case Report.

Authors:  Hamdy A Hendawy; Walid Mosallam; Mohamed E Abuelnaga; Amr M Sabry
Journal:  SN Compr Clin Med       Date:  2021-04-14

Review 3.  Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2.

Authors:  Alessandra Cenci; Iole Macchia; Valentina La Sorsa; Clemente Sbarigia; Valentina Di Donna; Donatella Pietraforte
Journal:  Front Microbiol       Date:  2022-04-21       Impact factor: 6.064

4.  A click-based modular approach to introduction of peroxides onto molecules and nanostructures.

Authors:  Alissa Horn; Patrick H Dussault
Journal:  RSC Adv       Date:  2020-12-16       Impact factor: 4.036

5.  Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.

Authors:  A Hernández; P J Papadakos; A Torres; D A González; M Vives; C Ferrando; J Baeza
Journal:  Rev Esp Anestesiol Reanim (Engl Ed)       Date:  2020-04-14

Review 6.  Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review.

Authors:  Giovanni Tommaso Ranaldi; Emanuele Rocco Villani; Laura Franza
Journal:  Med Gas Res       Date:  2020 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.